S. Allieu

Two-year outcomes of the APOLLON observational study of intravitreal aflibercept monotherapy in France in patients with diabetic macular edema

P. Massin, C. Chiquet, C. Creuzot-Garcher, 2022, Scientific Reports.

Safety and efficacy of a standardized intracameral combination of mydriatics and anesthetic for cataract surgery in type-2 diabetic patients

B. Cochener, P. Gain, A. Liekfeld, 2020, BMC Ophthalmology.

Is current age related macular degeneration self-monitoring a good tool for detecting exudative recurrence?

J. Daurès, S. Navarre, C. Chamard, 2019, Journal francais d'ophtalmologie.

Does HbA1c Level or Glomerular Filtration Rate Affect the Clinical Response to Endothelial Growth Factor Therapy (Ranibizumab or Aflibercept) in Diabetic Macular Edema? A Real-Life Experience

C. Creuzot-Garcher, M. Gillies, P. Gabrielle, 2023, Ophthalmology and Therapy.

One-year anti-VEGF therapy outcomes in diabetic macular edema based on treatment intensity: Data from the FRB! registry.

D. Squirrell, Lala Ceklic, A. Invernizzi, 2024, Ophthalmology. Retina.